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Introduction
In recent years, our understanding of genetic factors associ-
ated with multiple sclerosis (MS) has considerably increased 
as a result of new analytical approaches to genome-wide 
association studies, together with the large numbers of 
samples available through international collaborations. It 
is now clear that MS risk is multigenic, and that common 
variants (now numbering more than 150) contribute only a 
relatively small proportion to the overall heritability of MS. 
As a result, attention has once again turned to the possibil-
ity of identifying rare variants through a number of novel as 
well as more traditional methodologies. However, detecting 
effects of rare variants once again poses challenges of statis-
tical power, and several different approaches can be applied 
to manage this issue, some of which are illustrated below. In 
this month’s Journal Club we review five recent publications 
that have employed large international cohorts, multiplex 
families, or candidate gene approaches to investigate rare 
genetic variants and their association with MS risk.
Low‑frequency and rare‑coding variation 
contributes to multiple sclerosis risk
In this study, the International Multiple Sclerosis Genet-
ics Consortium (IMSGC) used exome arrays from a total 
of 36,219 MS cases and 38,629 controls from 12 countries 
to investigate rare variants in MS. Mixed linear models 
incorporating genotypic principal components were used to 
analyse association with disease. Seven rare variants were 
identified in six genes, although two variants were in link-
age disequilibrium with common variants already known to 
be associated with MS (TYK2 and GALC). The other vari-
ants were in genes not previously known to be associated 
with MS, but which are involved in the innate (NLRP8) and 
adaptive immune systems (HDAC7, PRF1, and PRKRA), 
and therefore, are plausible candidates for pathogenesis of 
MS. Interestingly, the minor alleles were protective in most 
cases, which is the reverse to that which is usually found 
with common variants.
Comment. This is an interesting and important study. 
The IMSGC has been very successful over the last 15 years 
in using genome-wide association studies to identify com-
mon variants associated with MS, and have now used 
newer genetic techniques in their established large cohort 
of patients to detect rare variants. This study adds to our 
knowledge about the genetic factors in MS pathogenesis. 
However, the rare variants identified contribute approxi-
mately 5% of MS heritability (in addition to the 19% herit-
ability contributed by common variants). This suggests that 
other variants also contribute to the genetic heritability of 
MS and that larger studies or alternative approaches may be 
required to discover them. In addition, more work is needed 
to understand the mechanisms by which the genes identified 
in this study may be relevant for MS pathogenesis.
International Multiple Sclerosis Genetics Consortium 
(2018) Cell. https ://doi.org/10.1016/j.cell.2018.09.049 (epub 
ahead of print).
Genome sequencing uncovers phenocopies 
in primary progressive multiple sclerosis
This study investigated genetic variation in primary progres-
sive MS (PPMS), with the hypothesis that genes known to 
cause diseases that are phenotypically similar to PPMS may 
also be relevant in PPMS pathogenesis. Specifically, this 
study focused on genes known to be associated with heredi-
tary spastic paraplegia (HSP). Whole genome sequencing 
data was used in samples from 38 PPMS patients and 81 
controls, and pathogenic variants known to occur in mono-
genic neurological disorders that were observed only in 
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the PPMS patients were then sequenced in two replication 
cohorts comprising a total of 746 PPMS, 3049 relapsing-
onset MS, and 1000 healthy controls. Additionally, the 
genetic burden of variants in genes associated with HSP 
was analysed in PPMS, relapsing-onset MS and healthy 
controls. Three variants were identified in PPMS patients: 
KIF5A (associated with spastic paraplegia 10), MLC1 (asso-
ciated with megalencephalic leukodystrophy with subcorti-
cal cysts), and REEP1 (associated with spastic paraplegia 
31), and the burden of genetic variants associated with HSP 
was higher in PPMS patients than controls.
Comment. Given the logistic challenges involved in 
detecting rare variants in MS, as illustrated by the previous 
paper, the approach taken in this study of targeting genes 
known to cause syndromes phenotypically similar to MS 
seems logical. Focussing on PPMS is an important aspect 
of this study, as it remains a less well-understood MS phe-
notype, and an improved understanding of pathogenesis 
may also lead to improved management and therapeutic 
strategies. Although the discovery cohort in this study was 
relatively small, the two-stage validation approach on larger 
cohorts of patients increases plausibility and robustness of 
the findings.
Jia X, Madireddy L, Caillier S et al (2018) Ann Neurol 
84(1):51–63.
Common genetic etiology between “multiple 
sclerosis‑like” single gene disorders 
and familial multiple sclerosis
This study hypothesised that genes causing diseases pheno-
typically similar to MS may also contain rare variants that 
are relevant for MS pathology. To investigate this, samples 
from a cohort of patients from British Columbia, Canada 
were used to examine rare variants in candidate genes as fol-
lows: 28 candidate genes were identified. Exome sequencing 
was available in 270 MS cases, and this was used to iden-
tify 57 rare variants present in the candidate genes. These 
variants were then genotyped in 830 MS cases and 2131 
controls to identify which variants occurred in MS cases 
but not controls. Finally, where family samples were also 
available, the remaining variants were analysed to look for 
segregation with the disease within families. This process 
identified a total of 9 variants in 6 genes, three of which were 
all seen within one multi-incident family (CLCN2, GALC, 
and POLG). The other three genes identified were CYP27A1, 
LYST and PDHA1.
Comment. The variants identified in this study are 
involved in cholesterol metabolism (CYP27A1) or mito-
chondrial function (POLG and PDHA1), suggesting addi-
tional mechanisms for pathogenesis of MS. This study also 
demonstrates that even within a single family there may be 
more than one genetic variant that could be relevant, and 
underlines the multigenic nature of MS and hints at further 
reasons for variability of outcome in MS.
Traboulsee AL, Sadovnick AD, Encarnacion M et al 
(2017) Hum Genet 136:705–714
Linkage analysis and whole exome 
sequencing identify a novel candidate gene 
in a Dutch multiple sclerosis family
This study investigated a large Dutch family with 11 affected 
individuals as well as unaffected individuals including obli-
gate carriers. The initial genome linkage analysis identi-
fied a potential region of interest on chromosome 7. Exome 
sequencing was then carried out on four affected family 
members which identified eight candidate rare variants. 
These variants were then genotyped in the whole family, and 
a single variant was found to segregate with disease located 
in the FKBP6 gene. However, no difference was found in 
the frequency of the variant when typed in 591 sporadic 
MS cases compared to healthy controls. FKBP6 is a recep-
tor involved in immunological function and prediction of 
structural effects of the variant suggests that it is likely to be 
damaging to the protein’s function.
Comment. In a similar fashion to other papers reviewed in 
this article, this study has identified a rare variant in a gene 
that has also been implicated in other genetic disorders; in 
this case Williams–Beuren syndrome which is associated 
with cardiovascular defects, learning difficulties and hyper-
calcaemia. This finding has not previously been reported in 
MS. Although this variant may be important for the patho-
genesis of MS in this family, the fact that the variant was 
no different in cases compared to controls limits its overall 
relevance to MS.
Mescheriakova JY, Verkerk AJMH, Amin N et  al 
(2018) Mult Scler 1352458518777202. https ://doi.
org/10.1177/13524 58518 77720 2 (epub ahead of print).
Purinergic receptors P2RX4 and P2RX7 
in familial multiple sclerosis
This study used exome sequencing data from the British 
Columbia patient cohort and a family with multiple affected 
members to investigate related candidate genes: The puriner-
gic receptors P2RX7 and P2RX4 are transmembrane cation 
channels known to be important in the pro-inflammatory 
cascade, and have previously been shown to modulate MS 
susceptibility. A rare three-variant haplotype in the P2RX7 
and P2RX4 genes was identified which segregated with MS 
within the family. The authors then went on to a functional 
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analysis of the variants, and were able to demonstrate 
impaired channel function, which led to a substantial reduc-
tion in phagocytic ability of the cell.
Comment. One of the key features of this work is its 
investigation of functional effects of newly described rare 
variants. This is clearly a necessary step to understand the 
potential biological role of these genetic variations and 
how they might lead to immune system dysfunction and/or 
precipitate the pathology known to be associated with MS. 
It also illustrates the value of family studies in identifying 
genetic variants associated with MS, although again it may 
be the case that these variants are less important in sporadic 
MS. Finally, the British Columbia cohort has a very high 
standard of clinical phenotyping and the two studies here 
described from this cohort illustrate the vital importance of 
detailed clinical phenotype for genetic studies.
Sadovnick AD, Gu BJ, Traboulsee AL et al (2017) Hum 
Mutat 38(6):736–744.
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